EW vs. IDXX: Edwards Lifesciences vs. IDEXX Laboratories Stock Comparison

Company Profile

Edwards Lifesciences (EW) and IDEXX Laboratories (IDXX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Edwards Lifesciences (EW) at 9.33%, which is closer to a typical peer reading.

For every dollar of sales, both Edwards Lifesciences (EW) at 15.30% and IDEXX Laboratories (IDXX) at 25.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Edwards Lifesciences (EW) at 30.15% and IDEXX Laboratories (IDXX) at 33.14% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Edwards Lifesciences (EW) at 11.55% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

IDEXX Laboratories (IDXX) at 22.59% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while IDEXX Laboratories (IDXX) at 0.52 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Neither Edwards Lifesciences (EW) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Edwards Lifesciences (EW) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

IDEXX Laboratories (IDXX) at 45.56 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.

Both look expensive on sales: Edwards Lifesciences (EW) at 8.80 sits in the upper P/S ratio quartile, and IDEXX Laboratories (IDXX) at 11.42 prices even higher, above its industry range.

Edwards Lifesciences (EW) at 5.41 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics